Lexology November 9, 2022
Baker & Hostetler LLP

Key Takeaways

In response to the COVID-19 pandemic, the White House Office of Science & Technology Policy and the Office of the National Coordinator for Health Information Technology take a major step towards testing interoperability capabilities in clinical trials.  The regulatory and technological framework for the interoperability of Electronic Health Records platforms could be applied to the clinical trials context. Shift towards the use of interoperable technologies could improve the collection and exchange of clinical trials data between institutions in emergent and non-emergent settings.

In response to the COVID-19 pandemic, the Biden administration recently announced its National Biodefense Strategy aimed at national preparedness for biological threats. The National Biodefense Strategy sets several targets for improved capabilities in order to respond to biologic...

Today's Sponsors

Transcarent
SalesSparx

Today's Sponsor

Health Edge

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Health IT, HIE (Interoperability), ONC, Pharma, Pharma / Biotech, Technology, Trends
Three Wild Health Technologies in (or Close to) Clinical Trials
How the Cloud Can Improve Data Sets for Real-World Evidence in Clinical Trials
Health Equity Barriers in Oncology Trials
Nationwide Children's Hospital AI spinoff acquired by new $200M clinical trial startup
Clinical trial company Science 37 buys life science assets from Vault Health

Share This Article